These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32031967)

  • 1. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease.
    Trentini A; Rosta V; Spadaro S; Bellini T; Rizzo P; Vieceli Dalla Sega F; Passaro A; Zuliani G; Gentili V; Campo G; Cervellati C
    Clin Chem Lab Med; 2020 Sep; 58(10):1749-1758. PubMed ID: 32031967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and total myeloperoxidase in coronary artery disease and relation to clinical instability.
    Gach O; Brogneaux C; Franck T; Serteyn D; Legrand V; Pierard LA; Magne J
    Acta Cardiol; 2015 Oct; 70(5):522-7. PubMed ID: 26567811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.
    Kubala L; Lu G; Baldus S; Berglund L; Eiserich JP
    Clin Chim Acta; 2008 Aug; 394(1-2):59-62. PubMed ID: 18440308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between myeloperoxidase levels and risk of coronary artery disease.
    Zhang R; Brennan ML; Fu X; Aviles RJ; Pearce GL; Penn MS; Topol EJ; Sprecher DL; Hazen SL
    JAMA; 2001 Nov; 286(17):2136-42. PubMed ID: 11694155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between adipokine and myeloperoxidase levels in patients with coronary artery disease.
    Basati G; Emami Razavi A; Abdi S; Sarrafzadegan N
    Acta Med Iran; 2015; 53(1):25-9. PubMed ID: 25597601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
    Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
    Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
    Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
    Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
    Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
    Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A
    Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts.
    Franck T; Kohnen S; Boudjeltia KZ; Van Antwerpen P; Bosseloir A; Niesten A; Gach O; Nys M; Deby-Dupont G; Serteyn D
    Talanta; 2009 Dec; 80(2):723-9. PubMed ID: 19836543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes.
    Song P; Xu J; Song Y; Jiang S; Yuan H; Zhang X
    Dis Markers; 2015; 2015():761939. PubMed ID: 26451069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
    Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
    Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual chronoamperometric detection of enzymatic biomarkers using magnetic beads and a low-cost flow cell.
    Moral-Vico J; Barallat J; Abad L; Olivé-Monllau R; Muñoz-Pascual FX; Galán Ortega A; del Campo FJ; Baldrich E
    Biosens Bioelectron; 2015 Jul; 69():328-36. PubMed ID: 25791338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.